Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AstroRx in ALS
NCT03482050Phase 2Completed
- Sponsor
- Kadimastem
- Start
- Apr 2018
- Primary completion
- Jun 2020
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of AstroRx in amyotrophic lateral sclerosis (ALS), sponsored by Kadimastem. Started Apr 2018; status: completed.
02
Drugs
AstroRx
03
Conditions
amyotrophic lateral sclerosis (ALS)
Beyond the preview
Go deeper on NCT03482050.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03482050.